Support

The product will be available as soon as medical certification is being passed. This date will vary from region to region (around 2022-2023). In the meantime, you are welcomed to subscribe to our newsletter in the home page in order to be updated about our progress.

February 2021 - K’Watch, which is still under development, along with K'apsul Glucose, will be able to measure glucose level in a continuous mode. The project has been financed by more than €10 million, allowing us to obtain good results during our pre-clinical trials.
Next steps: We are preparing the clinical trials, the final step before certification.

K’Watch measures very frequently the biomarker concentration (Glucose or Lactate). It provides updated information every 5 min to the user based on the previous measurements performed by the system for maximum precision.

K’apsul is a tiny consumable that needs to be plugged at the back of K’Watch. K’apsul can make unlimited measurements for a period of 7 days, after that it shall be changed. Each K’apsul is composed of biosensors and of SkinTaste technology, an array of micro-points that are in contact with the user's interstitial fluid. SkinTaste allows a bio-chemical analysis of the interstitial fluid to determine the level of a given biomarker (e.g.: Glucose or Lactate). While the user will feel the slight pressure of the probe pressing on their skin, they feel absolutely no pain as the sensor never reaches the pain nerves or blood vessel.

K’apsul sticks to the skin thanks to an advanced patch that enables it to move with the skin. The patch is much softer than traditional sticky patch from existing CGM (Continuous Glucose Monitors). This reduces the risk of irritation due to the patch and allows the user to remove K’apsul.

K’apsul is easy to insert and to remove from K’Watch. After 7 days of measurement, K’apsul just needs to be changed with a brand new one.

K’Watch will go through a medical certification process.  During this process, clinical tests must be performed and officially validated, thus ensuring the accuracy of measurements. To obtain the certification, K’Watch will need to be accurate enough for the given purpose.

We received many requests for it. So, it is on our list of projects. This is one of our priorities, but it will require the adult version to pass medical certification first, then we would be able to organize clinical trials for pediatric use.

Beyond the biomarker tracking (Glucose or Lactate via K'apsul), K’Watch can provide other useful information to the user:

• Time and date, it’s a watch!
• Activity tracking (steps, distance, calories)
• Heart rate
• Sleep quality
• Alarms: either traditional alarms or specific to warn the user in case of an hypoglycemia/ hyperglycemia episode

We are working on developing an iOS and an Android application. This will allow to provide more comprehensive data and added value services to the user. K'Watch will be securely connected to the cloud enabling, if the users agree, to share data with their family or caregivers.

The K’Watch should be priced at 199 $/€. The K’apsul Glucose sensors should be priced at around 99.90 $/€ per month. Price may change by launch time and according to regions and local duties and taxes.

The K’Watch Glucose pack contains:

• 1 K’Watch Glucose watch
• 1 charger
• 1 mobile app (free)
• 1 user manual

The K’Watch Athlete pack contains:

• 1 K’Watch Athlete watch
• 1 K’Watch Athlete armband
• 1 charger
• 1 mobile app (free)
• 1 user manual

Once the medical certification process for marketing K’Watch Glucose is finalized, a second process must be initiated so that it can be reimbursed by local social security and/or insurances. If we succeed in getting reimbursement, the level of reimbursement will vary depending on regions, payers and patient situation. We will keep you updated via our newsletter.

We plan to launch a clinical trial 6 months before the end of the project. As this process is strictly controlled, you can be informed through our newsletter.

PKvitality’s office is located in Paris area, France. The company also has employees in the USA and in Taiwan.